Graphic of doctors around a petri dish
·
4 Min Read

3 ways to slow spread of deadly antibiotic-resistant infections

Antibiotic-resistant infections kill 35,000-plus Americans annually. Learn what physicians and other health professionals should be doing.

Behavioral Health
Delegate Niva Lubin-Johnson, MD, speaking at 2019 HOD Interim Meeting.
·
4 Min Read

AMA develops Rx for drug prices that are high and rising

Arbitration can be used in determining price of prescription drugs that have insufficient competition, high list prices, or have seen unjustifiable price increases.

Behavioral Health
·
4 Min Read

AMA sharpens policy to promote reasonable drug prices

Physicians adopt principles for the use of drug price arbitration and international price indices.

Press Releases
·
3 Min Read

AMA statement on updated CDC report about antibiotic resistance

AMA is pleased that CDC has released an updated report on antibiotic resistance threats.

Press Releases
Hands lacing running shoes
·
3 Min Read

How Netflix-style plans could solve drug-spending dilemmas

States are locked in a zero-sum budget game when it comes to breakthrough medical treatments. Subscription drug pricing can help.

Behavioral Health
Prescription drugs in a shopping cart
·
3 Min Read

Why putting prices in EHRs will help doctors keep costs in check

Including prescription-drug prices in electronic health records would improve transparency while simultaneously strengthening the patient-doctor bond.

Digital
Two prescription bottles
·
3 Min Read

Access to prescription drugs: How the doctor’s role is changing

The landscape for prescription medications continues to evolve. This is what physicians should know about the changes and strategies to improve access.

Ethics
·
6 Min Read

July 25, 2019: National Advocacy Update

Surprise billing proposal and other legislation, DTC drug price disclosure and more in the latest AMA national health care advocacy news.

Advocacy Update
AMA members address HOD during 2019 Annual Meeting
·
3 Min Read

Time to scrutinize PBMs’ outsized role in Rx decision-making

The AMA calls for transparency and oversight of pharmacy benefit managers’ (PBM) operations.

Annual Meeting